187 related articles for article (PubMed ID: 9847366)
1. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity.
de Parseval A; Elder JH
J Virol; 1999 Jan; 73(1):608-17. PubMed ID: 9847366
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.
Phillips TR; Lamont C; Konings DA; Shacklett BL; Hamson CA; Luciw PA; Elder JH
J Virol; 1992 Sep; 66(9):5464-71. PubMed ID: 1323707
[TBL] [Abstract][Full Text] [Related]
3. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
4. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
[TBL] [Abstract][Full Text] [Related]
5. The bovine immunodeficiency virus: cloning of a tat/rev cDNA encoding a novel Tat protein with enhanced transactivation activity.
St-Louis MC; Abed Y; Archambault D
Arch Virol; 2005 Aug; 150(8):1529-47. PubMed ID: 15821973
[TBL] [Abstract][Full Text] [Related]
6. Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.
Chatterji U; de Parseval A; Elder JH
J Virol; 2002 Oct; 76(19):9624-34. PubMed ID: 12208941
[TBL] [Abstract][Full Text] [Related]
7. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
Benko DM; Schwartz S; Pavlakis GN; Felber BK
J Virol; 1990 Jun; 64(6):2505-18. PubMed ID: 2186172
[TBL] [Abstract][Full Text] [Related]
8. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative Rev proteins.
Stephens RM; Derse D; Rice NR
J Virol; 1990 Aug; 64(8):3716-25. PubMed ID: 2164593
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev-responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA.
Venkatesan S; Gerstberger SM; Park H; Holland SM; Nam Y
J Virol; 1992 Dec; 66(12):7469-80. PubMed ID: 1433526
[TBL] [Abstract][Full Text] [Related]
11. Identification of feline immunodeficiency virus rev gene activity.
Kiyomasu T; Miyazawa T; Furuya T; Shibata R; Sakai H; Sakuragi J; Fukasawa M; Maki N; Hasegawa A; Mikami T
J Virol; 1991 Aug; 65(8):4539-42. PubMed ID: 1649349
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines.
Tomonaga K; Miyazawa T; Kawaguchi Y; Kohmoto M; Inoshima Y; Mikami T
J Vet Med Sci; 1994 Feb; 56(1):199-201. PubMed ID: 8204756
[TBL] [Abstract][Full Text] [Related]
13. Simian immunodeficiency virus (SIVmac) exhibits complex splicing for tat, rev, and env mRNA.
Unger RE; Stout MW; Luciw PA
Virology; 1991 May; 182(1):177-85. PubMed ID: 2024463
[TBL] [Abstract][Full Text] [Related]
14. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
Thompson FJ; Elder J; Neil JC
J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus.
Li J; Zhang X; Bai B; Zhang M; Ma W; Lin Y; Wang X; Wang XF
J Virol; 2022 Dec; 96(24):e0121022. PubMed ID: 36448796
[TBL] [Abstract][Full Text] [Related]
16. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
Bilodeau PS; Domsic JK; Stoltzfus CM
J Virol; 1999 Dec; 73(12):9764-72. PubMed ID: 10559286
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.
Rosin-Arbesfeld R; Rivlin M; Noiman S; Mashiah P; Yaniv A; Miki T; Tronick SR; Gazit A
J Virol; 1993 Sep; 67(9):5640-6. PubMed ID: 8394464
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells.
Luo Y; Madore SJ; Parslow TG; Cullen BR; Peterlin BM
J Virol; 1993 Sep; 67(9):5617-22. PubMed ID: 8350414
[TBL] [Abstract][Full Text] [Related]
20. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
Furtado MR; Balachandran R; Gupta P; Wolinsky SM
Virology; 1991 Nov; 185(1):258-70. PubMed ID: 1926777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
